ENCLEAR THERAPIES
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClearโs proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The companyโs first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).
ENCLEAR THERAPIES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.encleartherapies.com
Total Employee:
1+
Status:
Active
Total Funding:
12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business PHP Google Google Cloud
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Convalesce
Stem Cell Based Therapy for Neurodegenerative diseases
Currus Biologics
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Genascence
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases
Ray Therapeutics
Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Stalicla
STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dolby Family Ventures
Dolby Family Ventures investment in Series A - EnClear Therapies
Quark Venture
Quark Venture investment in Series A - EnClear Therapies
Amgen Ventures
Amgen Ventures investment in Series A - EnClear Therapies
Tachyon Ventures
Tachyon Ventures investment in Series A - EnClear Therapies
Presight Capital
Presight Capital investment in Series A - EnClear Therapies
20/20 HealthCare Partners
20/20 HealthCare Partners investment in Series A - EnClear Therapies
Thiel Capital
Thiel Capital investment in Series A - EnClear Therapies
Peter Thiel
Peter Thiel investment in Series A - EnClear Therapies
Bioverge
Bioverge investment in Series A - EnClear Therapies
Global health sciences venture fund
Global health sciences venture fund investment in Series A - EnClear Therapies
Official Site Inspections
http://www.encleartherapies.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "EnClear Therapies"
About Us | EnClear Therapies
Our mission is to extend the lives of patients with CNS-related disease. Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation โฆSee details»
EnClear Therapies - Crunchbase Company Profile
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative diseaseSee details»
EnClear Therapies - LinkedIn
EnClear Therapies | 1,169 followers on LinkedIn. CSF based Therapies, Delivery and Diagnostics | At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop โฆSee details»
EnClear Therapies - 2025 Company Profile & Team - Tracxn
Jul 17, 2025 Explore EnClear Therapies' in-depth company profile, including funding details, key investors, leadership, and competitors.See details»
EnClear Therapies Company Profile - Office Locations ... - Craft
EnClear Therapies has 5 employees at their 1 location and $12 m in total funding,. See insights on EnClear Therapies including office locations, competitors, revenue, financials, executives, โฆSee details»
EnClear Therapies - Overview, News & Similar companies
Feb 19, 2020 View EnClear Therapies (www.encleartherapies.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โฆSee details»
EnClear Therapies: Revenue, Worth, Valuation & Competitors 2025
About EnClear Therapies EnClear Therapies is a Medical Equip related company founded in 2018 and based in Newburyport with 12 employees an estimated revenue of $3.3M, and. It has 10 โฆSee details»
EnClear Therapies Company Overview, Contact Details
Learn more about EnClear Therapies's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
EnClear Therapies 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for EnClear Therapies. Use the PitchBook Platform to explore the full profile.See details»
Home | EnClear Therapies
At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business utilizing our proprietary EnTrega CSF โฆSee details»
Enclear Therapies, Inc. - Drug pipelines, Patents, Clinical trials ...
May 8, 2025 Explore Enclear Therapies, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
EnClear Therapies - VentureRadar
Develops innovative biomedical technologies for controlled access, delivery, and modification of cerebrospinal fluid to treat neurodegenerative diseases in genetically defined patient โฆSee details»
EnClear Therapies - Executive Bio, Top Executies, and Transitions ...
View the organization profile of EnClear Therapies,EnClear Therapies ' Top Executives Anthony R. DePasqua MBA Co-Founder, Chief Executive Officer & Director 20+ years leading product โฆSee details»
The EnClear Team | EnClear Therapies
Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.See details»
EnClear Therapies - Profiles & Contacts - Crunchbase
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative diseaseSee details»
PROGRAMS - EnClear Therapies
Efficiently move to market & help patients with internal programs. Technology validation & new market expansion through partnerships.See details»
EnClear Therapies - VentureRadar
Associated sectors: Biotechnology; Biotech; Medical Devices; Health; BioRelax Unknown Privately Held BioRelax® with Kleinsche fields offers innovative, registered Class 1 medical โฆSee details»
Advisors & Collaborators - EnClear Therapies
Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.See details»
News - EnClear Therapies
Jun 8, 2021 Heather Gray-Edwards discusses Next Generation CNS Delivery at the 3rd Annual Gene Therapy for Neurological Disorders this week in Boston. EnClear Therapies is proud to โฆSee details»
Contact - EnClear Therapies
11/14/2023: Please be advised that the company has not sent any job offers. Any contact regarding jobs at EnClear Therapies as of today are false.See details»